The Current Ratio as of November 2024 (TTM) for Solid Biosciences Inc. (SLDB) is 7.85

According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.85. This represents a change of -30.47% compared to the average of 11.30 of the last 4 quarters.

Solid Biosciences Inc. (SLDB) Historical Current Ratio (quarterly & annually)

How has SLDB Current Ratio performed in the past?

The mean historical Current Ratio of Solid Biosciences Inc. over the last ten years is 7.30. The current 7.85 Current Ratio has changed 10.65% with respect to the historical average. Over the past ten years (40 quarters), SLDB's Current Ratio was at its highest in in the June 2018 quarter at 18.95. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Solid Biosciences Inc. (SLDB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Solid Biosciences Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Solid Biosciences Inc. (SLDB) Average Current Ratio

How has SLDB Current Ratio performed in the past?

The current Current Ratio of Solid Biosciences Inc. (SLDB) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Solid Biosciences Inc. (SLDB) Current Ratio vs. Peers

How is SLDB’s Current Ratio compared to its peers?

Solid Biosciences Inc.’s Current Ratio is less than Century Therapeutics, Inc. (10.39), less than Edgewise Therapeutics, Inc. (26.35), greater than C4 Therapeutics, Inc. (6.31), less than Mineralys Therapeutics, Inc. (8.55), less than Cullinan Oncology, Inc. (24.46), greater than TCR2 Therapeutics Inc. (2.77), less than Revolution Medicines, Inc. (14.24), greater than Black Diamond Therapeutics, Inc. (5.55), greater than Atreca, Inc. (1.58), greater than Passage Bio, Inc. (5.15), greater than Anebulo Pharmaceuticals, Inc. (3.45), less than Acrivon Therapeutics, Inc. Common Stock (12.75), less than PMV Pharmaceuticals, Inc. (13.98), less than Molecular Partners AG (14.33), less than Stoke Therapeutics, Inc. (0), greater than Monte Rosa Therapeutics, Inc. (5.09), greater than Cabaletta Bio, Inc. (6.03), less than Larimar Therapeutics, Inc. (8.11), less than Alector, Inc. (13.10), greater than null (3.29),

Build a custom stock screener for Solid Biosciences Inc. (SLDB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Solid Biosciences Inc. (SLDB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.